Disparities exist in survival among younger patients with acute leukemia
the ONA take:
Disparities in treatment outcomes for younger patients with acute promyelocytic leukemia (APL) exist among uninsured patients and those of Hispanic and black race/ethnicity, according to a new study published online ahead of print in the journal Cancer.
For the study, researchers sought to evaluate disparities in early death and survival in children, adolescents, and young adults with APL in California in the era of all-trans-retinoic acid (ATRA) treatment.
Researchers analyzed data from the California Cancer Registry to assess the 7-day and 30-day mortality and survival in 772 patients younger than 39 years of age with APL who were diagnosed between 1988 and 2011.
Results showed that the overall 30-day mortality decreased from 26% between 1988 and 1995 to 14% between 2004 and 2011, suggesting that the odds of death in the 30 days after diagnosis were 3 times higher during the first time period than the second time period.
Researchers found that lack of insurance and Hispanic and black race/ethnicity were associated with higher early death and reduced survival, suggesting that efforts should be made to improve access to effective treatment among those patients.
Disparities in treatment outcomes for younger patients with acute promyelocytic leukemia (APL) exist.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|